Freed, an AI clinician assistant startup, has raised $30m in Series A funding, with Sequoia Capital leading the investment round.

This capital infusion, which also saw contributions from Scale Venture Partners and other investors, increases Freed's total funding raised so far to $34m.

The AI clinician assistant is designed to alleviate the burden of medical documentation and address the clinician burnout crisis by automating the note-taking process.

Since its inception in 2023, the company has broadened its user base to include 96 different medical specialties, leveraging a direct-to-clinician model that circumvents the typically sluggish procurement cycles of hospital systems.

Freed was co-founded by CTO Andrey Bannikov and Erez Druk, who acts as CEO. Druk also brought in Yonatan Loewidt, an entrepreneur, as an early investor.

Loewidt said: “What drew me to Freed in the beginning was the relentless focus on solving a real, urgent problem for clinicians.

“Watching the early prototypes we built from scratch evolve into a tool that is now used and loved by thousands of clinicians is incredibly rewarding. Freed is more than a product—it’s a movement to help clinicians reclaim valuable time in their day-to-day lives.”

In conjunction with the funding news, Freed is introducing new AI-powered features that enhance its functionality beyond note-taking, propelling its development into a comprehensive AI clinician assistant.

These advancements include specialty-specific notes, a custom template builder for personalised documentation, pre-charting for patient summaries, and an EHR integration via a browser extension for seamless workflow integration.

Sequoia Capital partner Josephine Chen said: “Freed’s AI clinician assistant is transformative, saving tens of thousands of clinicians hours each week. Time and joy are given back to clinicians who, in turn, can provide even better care.

“The healthcare industry is embracing AI technology at an unprecedented pace - and this is only the beginning.”